Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study

by on 22 de gener de 2024 with No hi ha comentaris
  • Tabernero, J., Prager, G. W., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., . . . Taieb, J. (2023). Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study. Journal of Clinical Oncology, 41, 4-4. https://doi.org/10.1200/JCO.2023.41.4_suppl.4

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *